Single Blood Protein Identified as Top Marker for Fatty Liver Disease
Medical Xpress reports that a single blood protein stands out among 30 tests for assessing fatty liver disease . Medical Xpress reports that accurate assessment of metabolic dysfunction‑associated steatotic liver disease (MASLD) is essential for staging, treatment decisions, and therapy monitoring . Medical Xpress reports that liver biopsy has traditionally been required to diagnose and stage MASLD . Medical Xpress reports that new blood tests could provide a non‑invasive, inexpensive way to evaluate liver health in the general population . Medical Xpress reports that the LITMUS study compared 30 biomarkers and combinations to diagnose MASLD and its advanced stage, metabolic dysfunction‑associated steatohepatitis (MASH) . Medical Xpress reports that the study analyzed data from 1,590 MASLD patients who had been diagnosed via tissue biopsy .
Why it matters. Medical Xpress notes that this could enable broader, non‑invasive screening for liver health in the general population .